Parameter | Sex | Reference range | Group | Ingestion period | Follow-up period | |||
---|---|---|---|---|---|---|---|---|
0 w | 4 w | 8 w | 12 w | 16 w | ||||
TC (mg/dL) | 150-219 | A | 205.1 (3.6) | 202.8 (3.5) | 203.5 (3.5) | 203.1 (3.6) | 207.4 (3.8) | |
P | 197.6 (3.7) | 194.4 (3.5) | 197.1 (3.7) | 198.2 (3.7) | 200.7 (3.8)* | |||
LDL-C (mg/dL) | 70-139 | A | 128.7 (3.3) | 126.8 (3.2) | 126.6 (3.2) | 124.9 (3.3)* | 128.7 (3.4) | |
P | 121.5 (3.2) | 118.1 (3.2)* | 121.4 (3.4) | 119.6 (3.3) | 123.1 (3.4) | |||
HDL-C (mg/dL) | M | 40-80 | A | 52.5 (1.7) | 50.1 (1.5)** | 50.8 (1.6)* | 52.3 (1.6) | 53.9 (1.7) |
P | 51.2 (1.6) | 50.4 (1.9) | 50.1 (1.9) | 52.4 (1.9) | 54.0 (1.8)** | |||
F | 40-90 | A | 56.4 (1.4) | 55.1 (1.4)* | 55.0 (1.5) | 57.2 (1.4) | 57.6 (1.5) | |
P | 55.9 (1.4) | 54.3 (1.4)** | 55.5 (1.5) | 57.1 (1.6) | 57.3 (1.5) | |||
TG (mg/dL) | 50-149 | A | 106.2 (8.5) | 113.0 (8.3) | 123.9 (11.9)** | 113.1 (9.9) | 111.4 (8.0) | |
P | 112.3 (7.7) | 116.8 (7.6) | 105.9 (5.6) | 113.8 (7.0) | 112.5 (6.7) | |||
PL (mg/dL) | 150-250 | A | 218.3 (3.2) | 215.1 (2.9) | 217.1 (3.1) | 215.2 (3.2) | 219.9 (3.3) | |
P | 212.5 (3.0) | 210.7 (3.0) | 209.7 (2.9) | 212.0 (3.0) | 214.7 (2.8) | |||
FFA (mEq/L) | 0.10-0.81 | A | 0.539 (0.019) | 0.625 (0.025)** | 0.524 (0.021) | 0.545 (0.022) | 0.563 (0.019) | |
P | 0.542 (0.021) | 0.592 (0.023) | 0.545 (0.020) | 0.531 (0.019) | 0.523 (0.019) | |||
Glucose (mg/dL) | 70-109 | A | 93.4 (0.9) | 94.1 (0.9) | 93.8 (0.9) | 92.4 (0.9) | 94.4 (1.0) | |
P | 93.7 (1.0) | 93.2 (1.0) | 92.8 (1.0) | 92.4 (1.0)* | 94.6 (1.1) |